These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33501862)

  • 1. The potential of intranasal delivery of nanocrystals in powder form on the improvement of zaleplon performance:
    Latif R; Makar RR; Hosni EA; El Gazayerly ON
    Drug Dev Ind Pharm; 2021 Feb; 47(2):268-279. PubMed ID: 33501862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Targeted Intranasal Zaleplon Nano-emulsion: In-Vitro Characterization and Assessment of Gamma Aminobutyric Acid Levels in Rabbits' Brain and Plasma at Low and High Doses.
    Abd-Elrasheed E; El-Helaly SN; El-Ashmoony MM; Salah S
    Curr Drug Deliv; 2018; 15(6):898-906. PubMed ID: 29189154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-targeted intranasal zaleplon solid dispersion in hydrophilic carrier system; 2
    Abd-Elrasheed E; Nageeb El-Helaly S; El-Ashmoony MM; Salah S
    Drug Dev Ind Pharm; 2018 May; 44(5):741-749. PubMed ID: 29235903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia.
    Hosny KM; Banjar ZM
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1033-41. PubMed ID: 23795561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity.
    Haggag YA; Abosalha AK; Tambuwala MM; Osman EY; El-Gizawy SA; Essa EA; Donia AA
    Biopharm Drug Dispos; 2021 Jan; 42(1):12-23. PubMed ID: 33320969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X; Sun C; Jiang T; Zheng L; Wang T; Wang S
    J Pharm Pharm Sci; 2011; 14(2):196-214. PubMed ID: 21733409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micronized Zaleplon Delivery via Orodispersible Film and Orodispersible Tablets.
    Manda P; Popescu C; Juluri A; Janga K; Kakulamarri PR; Narishetty S; Narasimha Murthy S; Repka MA
    AAPS PharmSciTech; 2018 Apr; 19(3):1358-1366. PubMed ID: 29352403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid oral transmucosal delivery of zaleplon-lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation.
    Ali SA; Alhakamy NA; Hosny KM; Alfayez E; Bukhary DM; Safhi AY; Badr MY; Mushtaq RY; Alharbi M; Huwaimel B; Alissa M; Alshehri S; Alamri AH; Alqahtani T
    Drug Deliv; 2022 Dec; 29(1):2773-2783. PubMed ID: 36036168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro/in-vivo evaluation.
    Fouad SA; Shamma RN; Basalious EB; El-Nabarawi MA; Tayel SA
    Int J Pharm; 2016 May; 505(1-2):212-22. PubMed ID: 27063851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
    J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel instantly-dispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies, and in-vivo evaluation.
    Fouad SA; Shamma RN; Basalious EB; El-Nabarawi MM; Tayel SA
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1443-1450. PubMed ID: 29614890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability enhancement of zaleplon via proliposomes: Role of surface charge.
    Janga KY; Jukanti R; Velpula A; Sunkavalli S; Bandari S; Kandadi P; Veerareddy PR
    Eur J Pharm Biopharm; 2012 Feb; 80(2):347-57. PubMed ID: 22041602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Intramuscular Bioavailability of Cannabidiol Using Nanocrystals: Formulation, In Vitro Appraisal, and Pharmacokinetics.
    Fu X; Xu S; Li Z; Chen K; Fan H; Wang Y; Xie Z; Kou L; Zhang S
    AAPS PharmSciTech; 2022 Mar; 23(3):85. PubMed ID: 35288801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, Characterization and In Vivo Assessment of Repaglinide Nanosuspension for Oral Bioavailability Improvement.
    Zawar LR; Bari SB
    Recent Pat Drug Deliv Formul; 2018; 12(3):162-169. PubMed ID: 30003863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronotherapeutically Modulated Pulsatile System of Valsartan Nanocrystals-an In Vitro and In Vivo Evaluation.
    Biswas N; Kuotsu K
    AAPS PharmSciTech; 2017 Feb; 18(2):349-357. PubMed ID: 26961969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel nanocrystal-based solid dispersion with high drug loading, enhanced dissolution, and bioavailability of andrographolide.
    Ma Y; Yang Y; Xie J; Xu J; Yue P; Yang M
    Int J Nanomedicine; 2018; 13():3763-3779. PubMed ID: 29988798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation.
    Zhao X; Wang W; Zu Y; Zhang Y; Li Y; Sun W; Shan C; Ge Y
    Drug Deliv; 2014 Sep; 21(6):467-79. PubMed ID: 24479653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.